James G. Marken
2014
In 2014, James G. Marken earned a total compensation of $592.2K as Senior Vice President, Operations and Product Development at ANI Pharmaceuticals, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $119,250 |
|---|---|
| Option Awards | $115,765 |
| Salary | $259,455 |
| Stock Awards | $97,713 |
| Total | $592,183 |
Marken received $259.5K in salary, accounting for 44% of the total pay in 2014.
Marken also received $119.3K in non-equity incentive plan, $115.8K in option awards and $97.7K in stock awards.
Rankings
In 2014, James G. Marken's compensation ranked 9,707th out of 13,032 executives tracked by ExecPay. In other words, Marken earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,707 out of 13,032 | 26th |
Division Manufacturing | 3,670 out of 4,966 | 26th |
Major group Chemicals And Allied Products | 1,250 out of 1,686 | 26th |
Industry group Drugs | 992 out of 1,365 | 27th |
Industry Pharmaceutical Preparations | 762 out of 1,043 | 27th |
Source: SEC filing on April 6, 2017.
Marken's colleagues
We found three more compensation records of executives who worked with James G. Marken at ANI Pharmaceuticals in 2014.
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019